EP2744515
Samsett meðferð með and-CD19 mótefni og köfnunarefnissinnepi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.8.2012EP published:
9.2.2022EP application number:
12747923.6
EP translation filed:
15.3.2022Grant published:
15.4.2022EPO information:
European Patent Register
Max expiry date:
13.8.2032Expiry date:
13.8.2026Next due date:
31.8.2026
Title in English:
COMBINATION THERAPY WITH AN ANTI-CD19 ANTIBODY AND A NITROGEN MUSTARDLanguage of the patent:
English
Timeline
Today
14.8.2012EP application
9.2.2022EP Publication
15.3.2022Translation submitted
15.4.2022Registration published
13.8.2026Expires
Owner
Name:
Incyte CorporationAddress:
1801 Augustine Cut-Off, Wilmington, Delaware 19803, US
Inventor
Name:
AMERSDORFER, JuttaAddress:
85421 Hebertshausen, DE
Name:
STEIDL, StefanAddress:
81241 München, DE
Name:
WINDERLICH, MarkAddress:
81371 München, DE
Name:
KROHN, SusanneAddress:
81241 München, DE
Name:
ROJKJAER, LisaAddress:
CH-8908 Hedingen, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
11177658Date:
16.8.2011Country:
EP
Number:
201161523861 PDate:
16.8.2011Country:
US
Number:
201261647539 PDate:
16.5.2012Country:
US
Number:
201261654097 PDate:
1.6.2012Country:
US
Classification
Categories:
A61K 39/395, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 19.7.2022
Expires: 13.8.2023
Payer: Patice ehf.
Number: 12
Paid: 3.8.2023
Expires: 13.8.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 7.8.2024
Expires: 13.8.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 27.8.2025
Expires: 13.8.2026
Payer: Árnason Faktor ehf.